Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Amgen, Anheart, Aslan, Astrazeneca, Blue Lake, Cstone, Cyanvac, Ena Respiratory, Genfleet, Hanmi, Harbour Biomed, Hua Medicine, I-Mab, Innovent Biologics, JW, Kyowa Kirin, Laurent, Merck, Nrx, Pfizer, Pulmotect, RDIF, Regeneron, Ribomic, Ridgeback, Roche, Senhwa, Todos Medical, Trevena, VBI Vaccines.